An observational study in Liver Cirrhosis, sponsored by Kangbuk Samsung Hospital. Status unknown at 4 sites in South Korea. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2022-01-11.
Sponsored by Kangbuk Samsung Hospital · Observational
The aim of this prospective study is to evaluate the natural course and prognosis of hospitalized patients with liver cirrhosis.
The aim of this prospective study is to collect data on hospitalized patients with liver cirrhosis at four institutions in Korea (Kangbuk Samsung Hospital, Hallym University Dongtan Sacred Heart Hospital, Chosun University Hospital, and National Medical Center). If patients agree to participate in this clinical trial, the patients' data (such as age, sex, height, weight, nutrition status [RFH-NPT], history of medication, laboratory findings, endoscopic findings, and radiologic findings) will be collected in a research database. The research database will be updated, every 6 months, to include data on patients' disease outcomes and follow-up care.
1,668 studies on the registry are indexed under Liver Cirrhosis; 360 are open to participants now.
This study's planned enrollment of 336 is above the median of 152 across 605 observational studies indexed under Liver Cirrhosis.
Browse Liver Cirrhosis studies →Kangbuk Samsung Hospital is the lead sponsor of 63 studies on the registry; 9 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Hospitalized patients with liver cirrhosis
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
All-cause mortality
Death from any cause
Time frame: Up to 2 years
Liver-related mortality
Death from liver disease
Time frame: Up to 2 years
Cause of admission to hospital
Prevalence of cause of admission to hospital
Time frame: At baseline
This study is status unknown, as verified in Jan 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Kangbuk Samsung Hospital